GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Check Cap MBAI · USD

Health Care · US listing · 🇺🇸 United States

Compare

2.29

-4.98%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Net income

$4.1m

FY2021FY2025

Free cash flow

−$46,000

FY2021FY2025

Shareholders' equity

$3.4m

FY2021FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021
Research and development——$8.3m$14.3m$12.3m
Operating income−$2.4m−$25.9m−$19.3m−$20.0m−$17.3m
Net income$4.1m−$25.1m−$17.6m−$19.1m−$17.2m
Diluted earnings per share4.65-4.30-2.93-3.18-4.30

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Total assets$7.5m$377,000$25.0m$45.4m$55.7m
Cash and short-term investments$219,000$265,000$24.8m$41.7m$51.6m
Total liabilities$4.0m$1.8m$1.3m$4.1m$5.0m
Debt$16,000$136,000—$964,000$1.1m
Shareholders' equity$3.4m−$1.4m$23.7m$41.3m$50.7m
Shares outstanding1m6m6m6m4m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021
Cash from operations−$46,000−$8.0m−$17.0m−$18.7m−$16.3m
Capital spending——−$83,000−$486,000−$1.0m
Free cash flow−$46,000−$8.0m−$17.0m−$19.2m−$17.3m

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024
Operating income−$1.3m−$9.5m−$6.8m
Net income$5.2m−$25.1m−$6.3m
Diluted earnings per share0.89-4.30-1.08
Total assets$5.8m$377,000$18.1m
Cash and short-term investments$1.4m$265,000$17.8m
Debt$123,000$120,000—
Shareholders' equity$3.8m−$1.4m$17.2m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-50.9%——

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings2.6-1.7-5.2-2.9-8.4

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return197%-75%55%-70%118%-65%-23%-34%-63%16%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 7-to-1 reverse split · 13 Aug 2026
  • 20-to-1 reverse split · 25 Nov 2022

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.